Table II.
Applications of Membrane-Disruptive Peptides for the Delivery of Various Therapeutic Macromolecules
| AR-CPP | Membrane-disruptive peptide | Linkage between the AR-CPP and the membrane-disruptive peptide | Cargo delivered | Application in vitro | Application in vivo | Reference |
|---|---|---|---|---|---|---|
| TAT | HA2-TAT | Coincubation | Cre recombinase protein | Yes | No | (18) |
| TAT, Pen, Tp | Penetratin-HA2 | Coincubation | PNA | Yes | No | (62) |
| Pen | Penetratin-HA2 | Coincubation | siRNA | Yes | No | (63) |
| TAT | Modified HA2-TAT | Coincubation | Shepherdin peptide | Yes | No | (67) |
| TAT | Modified HA2-TAT | Coincubation | PM10 peptide | Yes | No | (68) |
| R11 | Modified HA2-TAT | Fusion protein | P53 protein | Yes | No | (69) |
| 46 | 43E | Ternary complex | Plasmid DNA | Yes | No | (70) |
| TAT | Histidine 10 | Fusion protein | Plasmid DNA | Yes | Yes | (71) |
Pen penetratin, Tp transportan, PNA peptide nucleic acid, R11 undecaarginine